Pharma Market Access Access solutions: the missing link that prevents biopharma i... We live in unprecedented times, where innovation in biosciences continues to accelerate.
Sales & Marketing The Pandemic Treaty and the opportunity to end ‘vaccine apar... Ben Hargreaves discovers why some have referred to the distribution of COVID-19 vaccines and treatments as a form of apartheid.
Patients Empowering rare disease patient advocacy organisations with ... Komodo Health’s president and co-founder, Web Sun, tells us about his company’s new partnership with the Chan Zuckerberg Initiative (CZI) to improve early diagnosis and advance research of rare dis
Patients What does the future of European healthcare look like? After the “stress test” of COVID, how can the sector create resilient, sustainable healthcare systems for the long term?
Patients Sponsored The invisible burden of RSV on older adults As we continue to move beyond the COVID-19 pandemic, we’ve seen many aspects of life returning to normal.
Patients Inside the pharmaceutical greenhouse For centuries, millions of people around the world have turned to the plants and trees around them to develop herbal and traditional remedies.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
